Delivery Order SPE2DB22D3301-SPE2DB24FZ2WA

Award Date 8/13/24
Potential Completion Date 8/14/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Provocholine Inhalation Solution in 18 mL packages. The award has a ceiling value of $2,136.52 and a completion date of September 17, 2024. The contract is a firm-fixed-price arrangement. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Provocholine Inhalation Solution, a medical product used for various treatments. The contract has a ceiling value of $6,822.62 and a period of performance through April 2025. It is a Firm Fixed Price contract, which indicates a set price for the goods or services provided. The...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Provocholine Inhalation Solution, a medical product, with a ceiling value of $1,650.39 and a completion date of February 7, 2025. This is an open competition contract with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Provocholine Inhal Soln Pack 18ML, a pharmaceutical product, with a firm fixed price of $5,501.30 and a completion date of May 19, 2025. The contract is not set aside and is awarded under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Provocholine Inhalation Solution, a medical product used for testing airway responsiveness. The contract has a ceiling value of $1,885.95 and a period of performance through May 6, 2025. It is a firm fixed-price contract, with no set-aside designation, indicating open competition....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Provocholine Inhalation Solution in 18 mL packs. The contract is a firm-fixed-price delivery order with a ceiling value of $3,339.22 and a performance period through March 3, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $4,857.15 firm fixed price delivery order is for Provocholine inhalation solution, a specialized pharmaceutical product. The delivery order is part of a larger, single-award indefinite delivery contract (IDC) between DLA Troop Support Medical and AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 with a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,460.90, is for the delivery of Provocholine Inhalation Solution Packs, a pharmaceutical product. The contract has an ultimate completion date of April 17, 2025. This contract is not set aside and is open to competition. AmerisourceBergen Drug Corp is the prime contractor and holds a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $1,650.39, is for the supply of PROVOCHOLINE INHAL SOLN PACK 18ML, a medical product. The contract has a firm fixed price pricing type and a period of performance through March 6, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and...
This federal contract award, valued at $3,300.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Provocholine Inhalation Solution, a medical product, with a period of performance through April 2025. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ2WA
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Provocholine Inhalation Solution, a medical product, for an estimated ceiling value of $1,668.75. The delivery order is placed under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which enables the government to efficiently procure a comprehensive range of pharmaceutical and medical supplies from Amerisourcebergen. This contract does not have a set-aside designation and is expected to be completed by August 14, 2024.

Generated 11/12/24, 9:13 AM